ANALYSIS OF THE RUSSIAN MARKET OF DRUGS USED FOR THE TREATMENT OF GASTRODUODENITIS IN ADOLESCENTS

Abstract

The Russian pharmaceutical market (RPhM) has a large assortment portfolio of medicines (MP) used to treat various diseases of the digestive system. But not all of these drugs are approved for use in children and adolescents. Due to their insufficient safety for this age group, it is necessary to be more careful in the selection of suitable medicines that will not be inferior in effectiveness to other drugs used in adults. So, in particular, some medicines used for the treatment of digestive organs are included in the List of vital and essential medicines, according to the decree of the Government of the Russian Federation dated 12.10.2019 No. 2406-r "On approval of the List of VED for 2023, as well as lists of medicines for medical use and the minimum range of medicines necessary for the provision of medical care." The purpose of this study was to analyze the range of drugs on the Russian pharmaceutical market used for the treatment of gastroduodenitis in adolescents. In the course of the study, various official information sources about medicines registered in the territory of the Russian Federation were reviewed and studied: the Register of Medicines of Russia "RADAR" (2023), Internet sources, collections and forms containing statistical data. Research methods: content analysis, ranking, graphic, structural, segmentation, comparative. A marketing study of the product portfolio was conducted, its structure was formed, and a macro-contour of RPhM drugs used for the treatment of gastroduodenitis in adolescents was developed. Research methods: content analysis, ranking, graphic, structural, segmentation, comparative. A marketing study of the product portfolio was conducted, its structure was formed, and a macro-contour of RPhM drugs used for the treatment of gastroduodenitis in adolescents was developed.